Brant A Inman

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Atezolizumab: a PD-L1 blocking antibody for bladder cancer
    Brant A Inman
    Urology, Duke University Medical Center
    Clin Cancer Res . 2016
  2. doi request reprint The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Hyperthermia 29:206-10. 2013
  3. doi request reprint Novel immunotherapeutic strategies in development for renal cell carcinoma
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    Eur Urol 63:881-9. 2013
  4. pmc An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    BJU Int 110:375-81. 2012
  5. pmc Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer
    Lee W Jones
    Duke University Medical Center, Durham, NC, USA
    BMC Cancer 10:531. 2010
  6. pmc The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, Durham, NC, 27710, USA
    BMC Urol 16:30. 2016
  7. doi request reprint Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer
    Joseph J Fantony
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    Cancer Biomark . 2017
  8. doi request reprint Anticipatory Positive Urine Tests for Bladder Cancer
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    Ann Surg Oncol . 2017
  9. pmc High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, Durham, NC
    Urol Oncol 34:407-14. 2016
  10. pmc Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA
    J Cancer Surviv 10:874-82. 2016

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Atezolizumab: a PD-L1 blocking antibody for bladder cancer
    Brant A Inman
    Urology, Duke University Medical Center
    Clin Cancer Res . 2016
    ..The toxicity profile of atezolizumab is also favourable. Trials are currently assessing whether atezolizumab is effective in earlier bladder cancer stages and in the first line metastatic setting...
  2. doi request reprint The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Hyperthermia 29:206-10. 2013
    ..This value is necessary for accurate modelling of fluid mechanics and heat transfer during hyperthermia treatments of bladder cancer...
  3. doi request reprint Novel immunotherapeutic strategies in development for renal cell carcinoma
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    Eur Urol 63:881-9. 2013
    ..The purpose of this report is to review immunotherapies under investigation for patients with renal cell carcinoma (RCC), the most common form of kidney cancer, for which the incidence and mortality rate continue to increase...
  4. pmc An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA
    BJU Int 110:375-81. 2012
    ..To determine whether prostate-specific antigen velocity (PSA-V), PSA doubling time (PSA-DT), or PSA percentage change (PSA-PC) add incremental information to PSA alone for community-based men undergoing prostate cancer (PCa) screening...
  5. pmc Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer
    Lee W Jones
    Duke University Medical Center, Durham, NC, USA
    BMC Cancer 10:531. 2010
    ....
  6. pmc The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, Durham, NC, 27710, USA
    BMC Urol 16:30. 2016
    ....
  7. doi request reprint Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer
    Joseph J Fantony
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    Cancer Biomark . 2017
    ..Abnormal methylation of urinary TWIST1 and NID2 conferred high sensitivity and specificity for the detection of urothelial carcinoma...
  8. doi request reprint Anticipatory Positive Urine Tests for Bladder Cancer
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    Ann Surg Oncol . 2017
    ..The aim of this study was to establish the criteria defining an anticipatory positive test for bladder cancer...
  9. pmc High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, Durham, NC
    Urol Oncol 34:407-14. 2016
    ..The objective of the current study was to determine the rate of VTE events in patients undergoing systemic therapy for UC and assess factors affecting this rate...
  10. pmc Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review
    Ajay Gopalakrishna
    Division of Urology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA
    J Cancer Surviv 10:874-82. 2016
    ..Our objective was to systematically review the literature on the associations between lifestyle factors, namely diet, physical activity, smoking status, and HRQOL in bladder cancer survivors...
  11. pmc Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer
    Richmond A Owusu
    Division of Urology, Duke University Medical Center, Box 2812, Durham, NC 27710, USA
    Biomed Res Int 2013:262313. 2013
    ..This will hopefully allow more widespread use of chemohyperthermia to all bladder cancer patients, including metastatic bladder cancer. ..
  12. pmc Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis
    Joseph J Fantony
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    Eur Urol Focus 2:189-196. 2016
    ..Postcystectomy bladder cancer (BCa) patients are at high risk for developing venous thromboembolism (VTE). The literature varies widely in the reporting of VTE in this population...
  13. pmc A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, North Carolina
    Int J Hyperthermia 30:171-5. 2014
    ..This paper aims to evaluate the safety and heating efficiency of external deep pelvic hyperthermia combined with intravesical mitomycin C (MMC) as a novel therapy for non-muscle-invasive bladder cancer (NMIBC)...
  14. pmc Miniature microwave applicator for murine bladder hyperthermia studies
    Sara Salahi
    Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA
    Int J Hyperthermia 28:456-65. 2012
    ..Of particular interest is a device that can selectively heat murine bladder...
  15. doi request reprint A systematic review of regional hyperthermia therapy in bladder cancer
    Thomas A Longo
    a Division of Urology, Duke University Medical Center, Durham, North Carolina
    Int J Hyperthermia 32:381-9. 2016
    ..Regional hyperthermia therapy (RHT) is a promising adjunctive therapy being tested in multiple clinical contexts...
  16. doi request reprint Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer
    Joseph J Fantony
    Division of Urology, Duke University Medical Center, Durham, NC
    Urol Oncol 33:387.e1-6. 2015
    ..In this expanded trial with subjects enrolled from another institution, we reexamine the diagnostic capabilities of the test to externally validate our previous study...
  17. ncbi request reprint Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, North Carolina, USA
    J Natl Compr Canc Netw 11:477-84. 2013
    ..A single dose of IVC administered within 24 hours of TUR of NMIBC was found to result in a reduction in tumor recurrence (RR, 0.67; 95% CI, 0.56-0.79). Patients with higher-risk tumor features seem to benefit at a similar rate...
  18. doi request reprint Clinical performance and utility of a DNA methylation urine test for bladder cancer
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, NC Electronic address
    Urol Oncol 32:51.e21-6. 2014
    ..We sought to externally validate a urine-based methylation assay combining TWIST1 and NID2 and assess its clinical utility...
  19. pmc Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer
    Agnes J Wang
    Department of Surgery, Division of Urology, Duke University Medical Center, Durham, NC 27713, USA
    J Endourol 27:288-93. 2013
    ..We evaluated the safety and feasibility of using a reverse thermosensitive polymer to improve dwell times of mitomycin C (MMC) in the upper tract...